Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Segment Information | ||||
| Number of reportable segment not disclosed | true | |||
| Revenues, net | $ 295,877 | $ 297,031 | $ 582,432 | $ 586,489 |
| Consolidated net sales | 295,877 | 297,031 | 582,432 | 586,489 |
| Cost of sales | 104,600 | 103,145 | 203,043 | 209,586 |
| Selling, general and administrative | 113,691 | 121,451 | 229,904 | 240,612 |
| Research and development | 23,125 | 25,016 | 47,366 | 48,885 |
| Operating income | 54,461 | 47,419 | 102,119 | 87,406 |
| Costs recognized on sale of acquired inventory | (373) | |||
| Recovery of assets held-for-sale | 6,789 | |||
| Operating Segments | ||||
| Segment Information | ||||
| Revenues, net | 296,264 | 295,686 | 577,910 | 583,413 |
| Other revenues | 1,849 | 5,439 | 4,152 | |
| Operating income | 93,047 | 90,352 | 179,638 | 175,170 |
| Operating Segments | Protein Sciences | ||||
| Segment Information | ||||
| Revenues, net | 215,084 | 211,551 | 417,272 | 416,086 |
| Cost of sales | 57,030 | 51,927 | 107,547 | 104,425 |
| Selling, general and administrative | 58,993 | 57,483 | 118,759 | 114,616 |
| Research and development | 14,446 | 15,029 | 28,638 | 29,392 |
| Operating income | 84,615 | 87,112 | 162,328 | 167,653 |
| Operating Segments | Diagnostics and Spatial Biology | ||||
| Segment Information | ||||
| Revenues, net | 81,180 | 84,135 | 160,638 | 167,327 |
| Cost of sales | 36,471 | 35,595 | 70,208 | 71,228 |
| Selling, general and administrative | 27,597 | 35,064 | 55,448 | 68,583 |
| Research and development | 8,680 | 10,236 | 17,672 | 20,000 |
| Operating income | 8,432 | 3,240 | 17,310 | 7,517 |
| Intersegment Eliminations | ||||
| Segment Information | ||||
| Revenues, net | (387) | (504) | (917) | (1,076) |
| Corporate, Non-Segment | ||||
| Segment Information | ||||
| Selling, general and administrative | (1,037) | (1,641) | (3,470) | (3,227) |
| Amortization of intangibles | (15,379) | (18,559) | (30,729) | (38,300) |
| Acquisition related expenses and other | (2,093) | (2,195) | (5,444) | (3,896) |
| Certain litigation charges | (2,140) | (1,386) | (4,549) | (1,678) |
| Stock based compensation, inclusive of employer taxes | (14,198) | (15,238) | (26,294) | (25,875) |
| Restructuring and restructuring-related costs | $ (3,739) | (3,287) | (11,249) | (14,309) |
| Recovery of assets held-for-sale | 6,789 | |||
| Impact of business held-for-sale(1) | $ (627) | $ (2,573) | $ (479) | |
| X | ||||||||||
- Definition Represents the amount of amortization of acquired intangible assets. No definition available.
|
| X | ||||||||||
- Definition The noncash expense during the period from the sale of acquired inventory written up to fair value in purchase accounting. No definition available.
|
| X | ||||||||||
- Definition Amount of impact on income from business held for sale. No definition available.
|
| X | ||||||||||
- Definition Indicates (true false) whether number of reportable segments are disclosed. No definition available.
|
| X | ||||||||||
- Definition Other revenues, excluding amounts attributable to assets held for sale. No definition available.
|
| X | ||||||||||
- Definition The amount of recovery of assets held-for-sale during the period. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|